Real‐world evidence for preventive effects of statins on cancer incidence: A trans‐Atlantic analysis
Main Authors: | Bjoern‐O Gohlke, Fabian Zincke, Andreas Eckert, Dennis Kobelt, Saskia Preissner, Juliane Maria Liebeskind, Nikolas Gunkel, Kerstin Putzker, Joe Lewis, Sally Preissner, Benedikt Kortüm, Wolfgang Walther, Cameron Mura, Philip E. Bourne, Ulrike Stein, Robert Preissner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.726 |
Similar Items
-
Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients
by: Jonas Wüster, et al.
Published: (2023-06-01) -
Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy
by: Mathias Dahlmann, et al.
Published: (2020-04-01) -
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature
by: Cameron Mura, et al.
Published: (2021-08-01) -
Immune Response and Metastasis—Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies
by: Sebastian Torke, et al.
Published: (2024-03-01) -
Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis
by: Shixian Yan, et al.
Published: (2023-12-01)